Form 4: Charles Schwab Director Carolyn Schwab-Pomerantz Receives Equity Compensation Grants

Charles Schwab Corporation Director Carolyn Schwab-Pomerantz was granted 1,462 restricted stock units and 3,646 nonqualified stock options under the company's 2022 Stock Incentive Plan.

Summary

• Carolyn Schwab-Pomerantz, a Director of The Charles Schwab Corporation (SCHW), acquired 1,462 shares of Common Stock in the form of restricted stock units (RSUs) on May 27, 2025.
• These RSUs were granted under the company's 2022 Stock Incentive Plan and are subject to a vesting schedule: 25% on the first anniversary of the grant date, 25% on the second anniversary, and 50% on the third anniversary.
• Additionally, Ms. Schwab-Pomerantz was granted 3,646 nonqualified stock options on May 27, 2025, with an exercise price of $88.63 per share.
• These stock options also vest according to the same schedule as the RSUs (25% on the first and second anniversary, 50% on the third anniversary) and have an expiration date of May 27, 2035.
• Following these transactions, Ms. Schwab-Pomerantz directly owns 9,624 shares of Common Stock and 3,646 nonqualified stock options.
• Her indirect beneficial ownership includes 1,520,398.6599 shares of Common Stock held by a Trust, 488,914 shares held by Spouse as Trustee, and 2,798 shares held by an LLC.

Sentiment

Score: 7

Explanation: The document reports routine equity grants to a director, which is a positive sign of aligning insider interests with shareholders and standard compensation practice. It does not indicate any negative events or significant changes in company operations.

Positives

• The grant of restricted stock units and stock options to a director aligns management incentives with shareholder interests, encouraging long-term value creation.
• The grants are part of the company's established 2022 Stock Incentive Plan, indicating a structured and transparent approach to executive and director compensation.

Future Outlook

The grants of restricted stock units and stock options are subject to a vesting schedule over three years, aligning the director's long-term interests with the company's performance and future growth, indicating a commitment to long-term value creation.

Industry Context

This Form 4 filing reflects routine equity compensation for a director at a major financial services firm like Charles Schwab. Such grants are common practice across the industry to incentivize long-term performance and retain key personnel, aligning their interests with shareholders.

Comparison to Industry Standards

• Equity grants to directors, including restricted stock units and stock options with multi-year vesting schedules, are standard compensation practices in the financial services industry.
• Companies like Morgan Stanley, Goldman Sachs, and Fidelity often utilize similar incentive plans to compensate their board members and executives, linking their remuneration to company performance and shareholder value creation.
• The specific amounts and vesting terms are typical for a director at a large-cap financial institution, reflecting a common approach to executive and director compensation within the sector.

Stakeholder Impact

• Shareholders: The grants align the director's interests with shareholders, potentially fostering long-term value creation.
• Employees: No direct impact on general employees is mentioned in this filing.

Next Steps

• Monitoring the vesting of the granted restricted stock units and stock options on their respective anniversary dates.
• Future Form 4 filings will report any subsequent changes in beneficial ownership by Carolyn Schwab-Pomerantz.

Key Dates

Keywords

Charles Schwab, SCHW, Form 4, Insider Transaction, Restricted Stock Units, Stock Options, Equity Grant, Director Compensation, Beneficial Ownership